Correlation between ABO/Rhesus blood group, Sickle cell disease (SCD) and Diabetes mellitus (DM) was investigated in Okwe, Asaba, Delta State and Ihiala, Anambra State,Nigeria. 100 proven cases of sickle cell patients (HBSS) from the sickle cell clinic in the General Hospital, Okwe, Asaba, Delta State, Nigeria, were studied. 200 normal individuals, 100 with genotype AA and 100 with genotype AS were taken as control for comparison from Okwe town. Furthermore, 50 proven cases of adults diabetic mellitus type2 from the diabetic clinic of our Lady's of Lourdes Hospital Ihiala, Anambra State were studied. Samples of 50 normal adult individuals were taken from the Hospital town as control for comparison. In the ABO/Rhesus blood group and SCD, the result showed that there was a correlation between ABO/Rhesus blood group and sickle cell disease (p<0.05). It was also observed that blood group O has the highest frequency distribution among the sicklers (63%), followed by blood group B (20%), then blood group A (17%), the least was AB blood group with O% distribution. For Rhesus blood system, the prevalence of Rh positive and Rh negative was studied against the hemoglobin genotypes. Rh positive was 96%for SS, 74% for AA, and 92% for AS. Rh negative was 4% for SS, 26%for AA and 8% for AS. This showed that Rh positive has the highest prevalence in SS while Rh negative has the lowest prevalence in SS,[P ABO\Rhesus blood group and DM, there was no correlation between ABO/Rhesus blood group and adult type 2 diabetes mellitus (P>0.05). It was also observed that blood group O (78%) was most commonly distributed in diabetes mellitus type2, followed by A (22%), blood group 0 (0%) and AB (0%) did not show any incidence of type2 diabetes mellitus. When Rh positive and Rh negative where matched against DM and the control, Rh positive was 94% in DM and 88% in control (P>0.05). Rh negative was 6% in DM and 12% in control, (P>0.05). It was observed that Rh positive was more in DM than the control, and Rh negative was more in control than in DM patient. Therefore, correlation between ABO/Rhesus blood group and diabetes mellitus type 2 was not proven. It is accordingly, concluded that ABO/Rhesus blood group has positive correlation with sickle cell disease and fell short of such correlation with diabetes mellitus.
membrane 2, 3 . Study in Nigeria showed that blood group O is the most common, followed by A, B, and least in AB with over 95% of Rhesus positive and 5% of Rhesus negative. A blood group has natural antibodies B in the plasma, B has antibodies A, AB has no antibodies in their plasma while 0 blood group has both A and B antibodies in the plasma. Sickle cell disease is the most prevalent hemoglobinopathy in human population. It is genetically transmitted in a recessive form. It is an inherited disorder/disease. WHO (2010) reported that 2% of new born in Nigeria were affected by the disease with a total of 150,000 affected children born every year in Nigeria 4 . Hemoglobin genotypes are inherited characters determined by different combination of these chains which include HbAA, HbAS, HbSD, HbSE and HbSS. HbSS differs from HbAA by the substitution of valine, a neutral amino acid for glutamic acid at position 6 in the Beta polypeptide chain [5] [6] [7] . DM is a disease characterized by impaired carbohydrate, fat and protein metabolisms caused by either lack of insulin secretion or decrease sensitivity of tissues to insulin, resulting in hyperglycemia in the blood. Three types of DM exist namely, Type1, Type2 and Type3 reported association between a particular ABO genotype and increased susceptibility to certain diseases 12, 13 . Homozygote dominance (HbAA) is reported to be most susceptible to plasmodial parasite infection than sickle cell heterozygote (HbAS). Sickle cell homozygote (HbSS) is most vulnerable to malaria infection than the other members of the genotypes 14 .
Blood group O is reported to have selective advantage against malaria infection.
The present study was therefore, under taken to investigate and elucidate whether there is a correlation between ABO blood group, sickle cell disease and diabetes mellitus and also to determine which ABO blood group is prevalent in SCD and DM.
Materials and methods

Materials
Materials used in this study included blood, stock sera (anti-A and anti B, and anti D), EDTA containers, sodium fluoride, 2ml and 5ml syringes, glucometer, microscope, tourniquet, tiles, clean slides, cotton wool, hand gloves, sodium dithionite, spirit.
Experimental protocol
All the patients in the study were seen in the General Hospital None has received any diabetic medication since live. They were identified also as being healthy if their venous blood glucose values were between 70 mg to 120 mg/dl. The anti-sera were qualified to ensure that they were genuine for accurate and reliable results. Blood samples were collected by venopuncture with 5 ml syringe and emptied into EDTA bottle and 2 ml fixed in a fluoride bottle. Blood sample in the EDTA bottles were used for blood grouping and sickling test while those in the fluoride bottles were used for random fasting blood sugar estimation as they did not take their morning meals.
Blood group was done serologically; sickling test was done by making a blood smears using reducing agent, sodium dithionite.
Blood smears were examined under microscope using x3 eye piece. Sickle red cells were observed. Blood sugar estimation was carried out with glucometer. Sugar strip was inserted into one strip glucometer, a drop of blood was placed on the sample spot. The meter issues results in mg/dl after 45 seconds Table 1 shows the distribution of the ABO blood groups among diabetes and non-diabetes. 50 patients with DM were studied in relation to the ABO blood group distribution. Blood group A is more common (22%) in patients than the control (20%). Blood group B is found to be absent (0%) in patients and common in control (10%). In AB phenotypes, both the patients and the control were zero percent. But in blood group 0, it is more numerous (78%) in patients than in control (70%). These differences between them are however not significant statistically (P>0.05). There is more blood group O in diabetics, and non-diabetics control. The difference between diabetes and non-diabetes control is not significant, P>0.05. Table 2 shows distribution of Rhesus factor between patients and non-diabetic control with Rhesus positive more in patients than the control (94% and 88%, respectively). In Rhesus negative, the diabetes and non-diabetes control are 6% and 12%, respectively. In comparison, Rhesus positive is more common (94%) in patients than control (88%) and Rhesus negative less common in patients (6%) than control (12%).
Statistical analysis
Results
These differences are however not significant statistically, (P>0.05). Rhesus -% 6% 12% x 2 -1.099, df -1; P>0.05 Table 3 shows the distribution of gender (sex) between patients and control. Females are found to be more in patients (62%) than in control (54%). Also it is found to be less for patients in males (38%) and more in control (46%). The distribution is not statistically significant P>O.O5. Table 5 shows distribution of ABO blood group among sicklers (HbSS) and HbAA genotype individuals. Blood group A is more in normal individuals (33%) and less in sickle s(17%), blood group B is the same for both groups (20%). Blood group AB is absent in sickles (0%) and present in normal individuals (3%).
But blood group O is more in patients (63%) and less in normal (AA) individuals (44%). This distribution is statistically significant (P<0.05). Table 6 Rhesus positive is higher in a sickler than the control (p<0.05).
Rhesus negative is less in a sickler than the normal individual p<0.05. 
Discussions
Blood group distribution among different population groups is an important consideration in health care 9 . Studies in Nigeria have revealed that ABO blood group distribution is in the following order O>B>A>AB.ie blood group O is most distributed and AB blood group is least distribution. The present study investigated the ABO blood group distribution among the sicklers and the diabetics patients to find out whether there is a correlation between them. This study was also extended to the Rhesus factor. The result showed that blood group A has 33% of HBAA. . Also, O and A blood group individuals are reported to be more susceptible to diabetes mellitus. On blood group and sickle cell disease, the study showed that blood group O is most commonly associated with genotype SS (SCD), followed by blood group B, then A group and the least prevalence is AB.
The gene frequencies in respect to ABO blood group can easily be shown as O>B>A>AB. This is in line with ABO blood group distribution in Nigeria, shown to be in this order O>B>A>AB. In Rhesus blood group, the prevalence of Rhesus positive in diabetic subject is 94% and 88% in non-diabetic subjects (p>0.05). The Rhesus negative in diabetic subjects is 6% while in non-diabetics, it is 12%, (p>0.05). In gender distribution between diabetics and non-diabetics, it was observed that females were found to be more in patients (62%) than in control (54%). Also it was found to be less for patients in males (38%) and more in control (46%)], statistically, the distribution is not significant p>0.05. This study therefore showed significant correlation between ABO/Rhesus blood group and sickle cell disease while it failed to show significant association/correlation between it (ABO/Rhesus blood group) and type 2 diabetes sickle cell disease and its correlation with diabetes mellitus was not proven.
Conclusion
The present study was conducted to justify the ABO/Rhesus blood group was interrelated with SCD and DM. The findings imply that ABO/Rhesus blood group has positive correlation with sickle cell disease and fell short of such correlation with diabetes mellitus.
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